Literature DB >> 6713713

Analysis of human sperm chromosome complements from a male heterozygous for a reciprocal translocation t(11;22)(q23;q11).

R H Martin.   

Abstract

A reciprocal translocation between chromosomes 11 and 22 (t(11;22)(q23;q11] is a site-specific translocation that is of particular interest because of the propensity for 3:1 segregation of the chromosomes during meiosis. There have been no published reports of chromosomally unbalanced offspring born as a result of adjacent 1 or 2 meiotic segregations in a heterozygote for this translocation. This could be explained by a meiotic mechanism which produces only 3:1 chromosomal segregations or by differential embryonic survival in which 2:2 adjacent segregations do not produce a viable pregnancy. To distinguish between these two possibilities, sperm chromosome complements from a man heterozygous for this 11;22 translocation were studied. The human sperm chromosomes were analysed after fertilization of zona pellucida-free golden hamster eggs. All possible 2:2 (alternate, adjacent 1, adjacent 2) and 3:1 segregations were observed and these segregations occurred in approximately equal frequencies. The frequency of other chromosome abnormalities, unrelated to the translocation, did not appear to be increased. These results indicate that the 11;22 translocation does not specifically cause 3:1 disjunction of chromosomes but that this segregation of chromosomes is more likely to result in a viable pregnancy.

Entities:  

Mesh:

Year:  1984        PMID: 6713713     DOI: 10.1111/j.1399-0004.1984.tb02004.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  28 in total

1.  Clustered 11q23 and 22q11 breakpoints and 3:1 meiotic malsegregation in multiple unrelated t(11;22) families.

Authors:  T H Shaikh; M L Budarf; L Celle; E H Zackai; B S Emanuel
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

2.  Meiotic studies of a human male carrier of the common translocation, t(11;22), suggests postzygotic selection rather than preferential 3:1 MI segregation as the cause of liveborn offspring with an unbalanced translocation.

Authors:  S J Armstrong; A S Goldman; R M Speed; M A Hultén
Journal:  Am J Hum Genet       Date:  2000-08-08       Impact factor: 11.025

3.  Involvement of 3:1 disjunction in the common reciprocal translocation t(11;22) (q23.3;q11.2)

Authors:  A C Chandley
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

4.  Sperm chromosome analysis of two males heterozygous for a t(2;17)(q35;p13) and t(3;8)(p13;p21) reciprocal translocation.

Authors:  J Jenderny
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

5.  Cytogenetic analysis of 400 sperm from three translocation heterozygotes.

Authors:  R H Martin; L Barclay; K Hildebrand; E Ko; S B Fowlow
Journal:  Hum Genet       Date:  1990-11       Impact factor: 4.132

6.  Direct segregation analysis of reciprocal translocations: a study of 283 sperm karyotypes from four carriers.

Authors:  F Pellestor; B Sèle; H Jalbert; P Jalbert
Journal:  Am J Hum Genet       Date:  1989-04       Impact factor: 11.025

7.  Sperm chromosome complements in a 47,XYY man.

Authors:  J Benet; R H Martin
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

8.  Human sperm chromosome studies in a reciprocal translocation t(2;5).

Authors:  C Templado; J Navarro; J Benet; A Genescà; M M Pérez; J Egozcue
Journal:  Hum Genet       Date:  1988-05       Impact factor: 4.132

9.  A unique case of der(11)t(11;22),-22 arising from 3:1 segregation of a maternal t(11;22) in a family with co-segregation of the translocation and breast cancer.

Authors:  Vaidehi Jobanputra; Wendy K Chung; April M Hacker; Beverly S Emanuel; Dorothy Warburton
Journal:  Prenat Diagn       Date:  2005-08       Impact factor: 3.050

10.  Meiotic and sperm chromosome analysis in a male carrier of an inverted insertion (3;10)(q13.2;p14p13).

Authors:  A S Goldman; R H Martin; R Johannisson; C P Gould; E V Davison; J E Emslie; J Burn; M A Hultén
Journal:  J Med Genet       Date:  1992-07       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.